Alkami Technology (NASDAQ: ALKT) director granted 11,357 RSUs in equity award

Rhea-AI Filing Summary

ALKAMI TECHNOLOGY, INC. director Raphael Osnoss received an equity award of 11,357 restricted stock units (RSUs). The RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before the Annual Meeting following the grant date. Each RSU converts into one share of common stock upon settlement, and the reporting person has elected to defer receipt of these shares under the company’s 2021 Incentive Plan. Following this grant, Osnoss directly holds 53,313 shares of common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Osnoss Raphael

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,357	$0.00	--

Holdings After Transaction: Common Stock — 53,313 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 11,357 units Price per RSU: $0.00 per share Shares after transaction: 53,313 shares +1 more

4 metrics

RSUs granted 11,357 units Restricted stock units awarded to director on grant date

Price per RSU $0.00 per share Stated transaction price for the RSU grant

Shares after transaction 53,313 shares Total common stock directly held after the grant

Vesting trigger Earlier of 1-year or next Annual Meeting Time-based vesting schedule for RSUs

Key Terms

restricted stock units (RSUs), Annual Meeting, grant date, 2021 Incentive Plan

4 terms

restricted stock units (RSUs) financial

"Represents restricted stock units (RSUs) which vest in full on the earlier of"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Annual Meeting financial

"earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting"

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

grant date financial

"earlier of (i) the first anniversary of the grant date and (ii)"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

2021 Incentive Plan financial

"elected to defer receipt of these shares under the terms of the 2021 Incentive Plan"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Osnoss Raphael

(Last) (First) (Middle)

C/O ALKAMI TECHNOLOGY, INC.

5601 GRANITE PARKWAY, SUITE 120

(Street)

PLANO TEXAS 75024

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ALKAMI TECHNOLOGY, INC. [ ALKT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		A		11,357(1)	A	$0	53,313	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units (RSUs) which vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date. Each RSU represents a contingent right to receive one share of common stock. The reporting person elected to defer receipt of these shares under the terms of the 2021 Incentive Plan.

Remarks:

	/s/ Douglas A. Linebarger, as Attorney-in-Fact for Raphael Osnoss	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ALKT director Raphael Osnoss report on this Form 4?

Raphael Osnoss reported receiving 11,357 restricted stock units (RSUs) of Alkami Technology common stock as a grant. The award is compensation rather than a market purchase, with no cash price per share and standard director vesting conditions attached.

How and when do Raphael Osnoss’s new ALKT RSUs vest?

The 11,357 RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before the next Annual Meeting. Once vested, each RSU represents a right to receive one share of Alkami Technology common stock upon settlement.

Did Raphael Osnoss buy or sell ALKT shares in the open market?

No open-market buy or sell occurred. The Form 4 shows a grant of 11,357 restricted stock units at a stated price of $0.00 per share, reflecting equity compensation rather than a discretionary market trade in Alkami Technology stock.

What is Raphael Osnoss’s ALKT share ownership after this RSU grant?

After the RSU award, Osnoss directly holds 53,313 shares of Alkami Technology common stock. This figure reflects his position following the reported grant and helps indicate the scale of his overall equity exposure to the company.

Did Raphael Osnoss defer his ALKT RSU award under the 2021 Incentive Plan?

Yes. The filing notes Osnoss elected to defer receipt of the shares underlying the 11,357 RSUs under Alkami Technology’s 2021 Incentive Plan, affecting when he actually receives the common stock, though vesting terms remain as disclosed.

What does each ALKT restricted stock unit (RSU) granted to Raphael Osnoss represent?

Each RSU represents a contingent right to receive one share of Alkami Technology common stock upon settlement. The RSUs vest based on time and board service conditions, then convert into actual shares according to the director’s deferral election under the 2021 Incentive Plan.